REFERENCES :

1) Vassy JL, Lu B, Ho YL, Galloway A, Raghavan S, Honerlaw J, Wilson PW. Estimation of atherosclerotic cardiovascular disease risk among patients in the Veterans Affairs Health Care System. JAMA Netw Open. 2020;3(7):e208236. 

doi:10.1001/jamanetworkopen.2020.8236.
2) Baker LA A, Aldin SZJ. Association of some biochemical parameters and blood pressure among males with hypertension in the camps of Nineveh province, Iraq. J Popul Ther Clin Pharmacol. 2022;29(04):167-176. doi:10.47750/jptcp.2022.979.
3) Abba MS, Nduka CU, Anjorin S, Zanna FH, Uthman OA. Socioeconomic macro-level determinants of hypertension: Ecological analysis of 138 low- and middle-income countries. J Cardiovasc Dev Dis. 2023;10(2):57. doi:10.3390/jcdd10020057.
4) Mansouri A, Khosravi A, Mehrabani-Zeinabad K, Kopec JA, Adawi KI, Lui M, Sarrafzadegan N. Trends in the burden and determinants of hypertensive heart disease in the Eastern Mediterranean region, 1990–2019: an analysis of the Global Burden of Disease Study 2019. eClinicalMedicine. 2023. doi:10.1016/j.eclinm.2023.102034.
5) Raleigh V, Jefferies D, Wellings D. Cardiovascular diseases in England: supporting leaders to take action. https://www.kingsfund.org.uk/publications/cardiovascular-disease-england.
6) Højstrup S, Thomsen JH, Prescott E. Disparities in cardiovascular disease and treatment in the Nordic countries. Lancet Reg Health–Eur. 2023. doi:10.1016/j.lanepe.2023.100699.
7) Saka M, Shabu S, Shabila N. Prevalence of hypertension and associated risk factors in older adults in Kurdistan, Iraq. East Mediterr Health J. 2020; 26(3):268-275.
8) Bennet L, Agardh C, Lindblad U. Cardiovascular disease in relation to diabetes status in immigrants from the Middle East compared to native Swedes: a cross-sectional study. BMC Public Health. 2013; 13(1). Doi: 10.1186/1471-2458-13-1133.
9) Budrevičiūtė A, Damiati S, Sabir DK, Önder K, Schuller-Goetzburg P, Plakys G, Katileviciute A, Khoja SM, Kodzius R. Management and Prevention Strategies for Non-communicable Diseases (NCDs) and their risk factors. Front Public Health. 2020;8. doi:10.3389/fpubh.2020.574111.
10) Muhammed S, Sardar M. Prevalence of cardiovascular disease risk factors among secondary school pupils in Sulaimani city, Kurdistan-Iraq: A cross-sectional study. doi:10.32007/jfacmedbagdad.2050.
11) Loukili H, Malka G, Landrault H, Frej D, Amine M. Cardiovascular diseases risk factors among young adults: A STEPWise-Approach-Based study in three university setups in Morocco. Open Public Health J. 2020;13(1):464-469. 

doi:10.2174/1874944502013010464.
12) Iyanda A, Ade-Oni A, Omiyefa S, Krishnan B. Prevalence, spatial pattern, and predictors of cardiovascular and chronic diseases: A cross-sectional study. doi:10.21203/rs.3.rs-2861281/v1.
13) Mansour AA. Prevalence and control of hypertension in Iraqi diabetic patients: a prospective cohort study. Open Cardiovasc Med J. 2012;6:68. doi:10.2174/1874192401206010068.
14) Dyball D, Evans S, Boos CJ, Stevelink S, Fear NT. The association between PTSD and cardiovascular disease and its risk factors in male veterans of the Iraq/Afghanistan conflicts: a systematic review. Int Rev Psychiatry. 2019;31(1):34-48. 

doi:10.1080/09540261.2019.1580686.
15) Bhatnagar P, Wickramasinghe K, Williams J, Rayner M, Townsend N. The epidemiology of cardiovascular disease in the UK 2014. Heart. 2015;101(15):1182-1189. doi:10.1136/heartjnl-2015-307516.
16) Poznyak AV, Sadykhov NK, Kartuesov AG, Borisov EE, Melnichenko AA, Grechko AV, Orekhov AN. Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment. Front Cardiovasc Med. 2022;9. doi:10.3389/fcvm.2022.959285.
17) Zardawi F, Gul S, Abdulkareem A, Sha A, Yates J. Association between periodontal disease and atherosclerotic cardiovascular diseases: revisited. Front Cardiovasc Med. 2021; 7. doi:10.3389/fcvm.2020.625579.
18) Mohamed AS, Alshekhani MAM. Risk factors for stroke in Sulaimaniyah, Iraqi Kurdistan Region, Iraq. Int J Clin Med. 2016. doi:10.4236/ijcm.2016.79070.
19) Dharmashankar K, Widlansky ME. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep. 2010;12:448-455. doi:10.1007/s11906-010-0150-2.
20) Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):1-19. doi:10.1186/s12933-018-0728-6.
21) Nassr OA, Forsyth P. Evaluation of blood pressure control and associated factors among patients with hypertension in Iraq: A prospective cross-sectional study. J Pharm Bioallied Sci. 2019;11(3):232. doi:10.4103/jpbs.jpbs_82_19.
22) Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982-3021. doi:10.1016/j.jacc.2020.11.010.
23) Jimenez MTB, Hahad O, Kuntic M, Daiber A, Münzel T. Noise, air, and heavy metal pollution as risk factors for endothelial dysfunction. Eur Cardiol Rev. 2023. https://www.ecrjournal.com/articles/noise-air-and-heavy-metal-pollution-risk-factors-endothelial-dysfunction.
24) Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75(2):285-292. doi:10.1161/HYPERTENSIONAHA.119.14240.
25) Gallo G, Volpe M, Savoia C. Endothelial dysfunction in hypertension: current concepts and clinical implications. Front Med. 2022;8. doi:10.3389/fmed.2021.798958.